Jean Ford

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. ncbi Understanding disparities in asthma outcomes among African Americans
    Jean G Ford
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Clin Chest Med 27:423-30, vi. 2006
  2. ncbi Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
    Jean G Ford
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Cancer 112:228-42. 2008
  3. ncbi Defining "success" in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach
    Shari Bolen
    Department of Medicine, Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Cancer 106:1197-204. 2006
  4. ncbi Invited commentary: Attendance and absence as markers of health status--the example of active and passive cigarette smoking
    Anthony J Alberg
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Am J Epidemiol 157:870-3. 2003
  5. ncbi Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials
    Gabriel Y Lai
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Welch 615 N. Wolfe St. E6531, Baltimore, MD 21205, USA
    Clin Trials 3:133-41. 2006
  6. ncbi Provider roles in the recruitment of underrepresented populations to cancer clinical trials
    Mollie W Howerton
    Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
    Cancer 109:465-76. 2007
  7. ncbi A genome-wide association study on African-ancestry populations for asthma
    Rasika A Mathias
    Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, MD, USA
    J Allergy Clin Immunol 125:336-346.e4. 2010
  8. ncbi A culturally targeted intervention to promote breast cancer screening among low-income women in East Baltimore, Maryland
    Mary A Garza
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Cancer Control 12:34-41. 2005
  9. ncbi Association between lifestyle factors and CpG island methylation in a cancer-free population
    Mariana Brait
    Department of Otolaryngology Head and Neck Surgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, USA
    Cancer Epidemiol Biomarkers Prev 18:2984-91. 2009
  10. ncbi Applying justice in clinical trials for diverse populations
    Jon Tilburt
    Department of Clinical Bioethics, National Institutes of Health, Bethesda, MD, USA
    Clin Trials 4:264-9. 2007

Research Grants

Collaborators

Detail Information

Publications26

  1. ncbi Understanding disparities in asthma outcomes among African Americans
    Jean G Ford
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Clin Chest Med 27:423-30, vi. 2006
    ..An overview of factors that may contribute to disparities in asthma prevalence, morbidity, and mortality,including contextual factors, is provided...
  2. ncbi Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
    Jean G Ford
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Cancer 112:228-42. 2008
    ....
  3. ncbi Defining "success" in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach
    Shari Bolen
    Department of Medicine, Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Cancer 106:1197-204. 2006
    ....
  4. ncbi Invited commentary: Attendance and absence as markers of health status--the example of active and passive cigarette smoking
    Anthony J Alberg
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Am J Epidemiol 157:870-3. 2003
  5. ncbi Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials
    Gabriel Y Lai
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Welch 615 N. Wolfe St. E6531, Baltimore, MD 21205, USA
    Clin Trials 3:133-41. 2006
    ..The available evidence cannot be generalized to these heterogeneous groups. Further study is needed on efficacious strategies for recruitment of underrepresented populations into cancer-related trials...
  6. ncbi Provider roles in the recruitment of underrepresented populations to cancer clinical trials
    Mollie W Howerton
    Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
    Cancer 109:465-76. 2007
    ..The purpose of the current systematic review was to describe provider-related factors influencing recruitment of underrepresented populations to cancer clinical trials...
  7. ncbi A genome-wide association study on African-ancestry populations for asthma
    Rasika A Mathias
    Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, MD, USA
    J Allergy Clin Immunol 125:336-346.e4. 2010
    ..Of the limited genetic studies performed on populations of African descent, notable differences in susceptibility allele frequencies have been observed...
  8. ncbi A culturally targeted intervention to promote breast cancer screening among low-income women in East Baltimore, Maryland
    Mary A Garza
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Cancer Control 12:34-41. 2005
    ..This culturally targeted intervention resulted in an unprecedented screening rate among low-income African American women in Baltimore, Maryland...
  9. ncbi Association between lifestyle factors and CpG island methylation in a cancer-free population
    Mariana Brait
    Department of Otolaryngology Head and Neck Surgery, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland 21231, USA
    Cancer Epidemiol Biomarkers Prev 18:2984-91. 2009
    ..It is important to reveal the molecular changes related to risk factors that could facilitate early detection, prevention, and overall control of cancer...
  10. ncbi Applying justice in clinical trials for diverse populations
    Jon Tilburt
    Department of Clinical Bioethics, National Institutes of Health, Bethesda, MD, USA
    Clin Trials 4:264-9. 2007
    ..However, doing so involves clarifying how to meet the demands of justice, or fairness, which provides the ethical mandate to enhance broad trial representation...
  11. ncbi The science of recruiting minority populations to screening trials
    Jean G Ford
    Clin Trials 1:341-2. 2004
  12. ncbi Reducing disparities in asthma care: priorities for research--National Heart, Lung, and Blood Institute workshop report
    Robert C Strunk
    Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63108, USA
    J Allergy Clin Immunol 109:229-37. 2002
    ..Research is encouraged to identify strategies that improve cultural adaptation and adoption of proven programs in a variety of populations...
  13. ncbi Risk for asthma in 1-year-old infants residing in New York City high-risk neighborhoods
    Ilan H Meyer
    Mailman School of Public Health, Columbia University, Columbia Center for Children's Environmental Health, New York, New York 10032, USA
    J Asthma 40:545-50. 2003
  14. ncbi Daily versus as-needed corticosteroids for mild persistent asthma
    Homer A Boushey
    University of California at San Francisco, San Francisco, USA
    N Engl J Med 352:1519-28. 2005
    ..Further studies are required to determine whether this novel approach to treatment should be recommended...
  15. ncbi Roles of interleukin-13 and interferon-gamma in lung inflammation
    Gabriele Grunig
    Department of Pathology, Columbia University, New York, NY, USA
    Chest 121:88S. 2002
  16. ncbi Significant variability in response to inhaled corticosteroids for persistent asthma
    Stanley J Szefler
    National Jewish Medical and Research Center, Department of Pediatrics, Denver, CO 80206, USA
    J Allergy Clin Immunol 109:410-8. 2002
    ..It is possible that higher doses of ICSs are necessary to manage more severe patients or to achieve goals of therapy not evaluated in this study, such as prevention of asthma exacerbations...
  17. ncbi Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)
    Anthony J Alberg
    Hollings Cancer Center, Medical University of South Carolina, 86 Jonathan Lucas St, PO Box 250955, Charleston, SC 29425, USA
    Chest 132:29S-55S. 2007
    ..The objective of this study was to summarize the published literature concerning the epidemiology of lung cancer...
  18. ncbi Asthma-related limitations in sexual functioning: an important but neglected area of quality of life
    Ilan H Meyer
    Harlem Lung Center, Division of Pulmonary and Critical Care Medicine, and Columbia University, Mailman School of Public Health, New York, NY 10032, USA
    Am J Public Health 92:770-2. 2002
  19. ncbi Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma
    Stephen C Lazarus
    University of California, San Francisco, 505 Parnassus Avenue, M 1083, San Francisco, CA 94143 0111, USA
    Am J Respir Crit Care Med 175:783-90. 2007
    ..One-quarter to one-third of individuals with asthma smoke, which may affect response to therapy and contribute to poor asthma control...
  20. ncbi Systemic effect comparisons of six inhaled corticosteroid preparations
    Richard J Martin
    National Jewish Medical and Research Center, Denver, Colorado 80206, USA
    Am J Respir Crit Care Med 165:1377-83. 2002
    ..This study represents the first step in evaluation of ICS efficacy based on equisystemic (cortisol suppression) effects of a given ICS, rather than doses judged arbitrarily to be comparable on a microgram basis...
  21. ncbi ADAM33 is not associated with asthma in Puerto Rican or Mexican populations
    Denise L Lind
    University of California at San Francisco, San Francisco, CA 94143-0833, USA
    Am J Respir Crit Care Med 168:1312-6. 2003
    ..We conclude that the ADAM33 gene is not an important risk factor for asthma or for asthma-associated phenotypes in Mexicans or in Puerto Ricans...
  22. ncbi Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma
    Esteban Gonzalez Burchard
    University of California, San Francisco, 94143 0833, USA
    Am J Respir Crit Care Med 169:386-92. 2004
    ..We conclude that Puerto Ricans with asthma respond less to albuterol than do Mexicans with asthma. These findings underscore the need for additional research on racial/ethnic differences in asthma morbidity and response to therapy...
  23. ncbi Predicting asthma morbidity in Harlem emergency department patients
    Gene R Pesola
    Harlem Lung Center and Hospital Emergency Department, Columbia University, New York, NY, USA
    Acad Emerg Med 11:944-50. 2004
    ..To determine predictors of asthma morbidity in African American patients with asthma. Proxies for asthma morbidity were emergency department (ED) visits for asthma and hospitalizations for asthma...
  24. ncbi Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
    Elliot Israel
    Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Lancet 364:1505-12. 2004
    ..However, the existence of any genotype-dependent difference has not been tested in a prospective clinical trial...
  25. ncbi Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma
    Shweta Choudhry
    University of California San Francisco, San Francisco, CA 94143 0833, USA
    Am J Respir Crit Care Med 171:563-70. 2005
    ..We tested the association of beta(2)AR genotypes with asthma severity and bronchodilator response to albuterol in Puerto Ricans and Mexicans with asthma...
  26. ncbi CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma
    Shweta Choudhry
    University of California San Francisco, DNA Bank Lung Biology Center, San Francisco General Hospital, Bldg 30, 5th Floor, Room 3501H, 1001 Potrero Avenue, San Francisco, CA 94110, USA
    Am J Respir Crit Care Med 172:173-82. 2005
    ..A recent family-based genomewide screen revealed linkage between the 5q31 region and the diagnosis of asthma, but only in those exposed to environmental tobacco smoke (ETS). Among the candidate genes in this region is CD14...

Research Grants4

  1. Determinants of asthma severity in Harlem (DASH)
    Jean Ford; Fiscal Year: 2005
    ..The potential public health benefits are critical for the asthmatic population in general. ..